Production (Stage)
Aquestive Therapeutics, Inc.
AQST
$2.35
$0.062.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.04% | -8.15% | -13.33% | -5.60% | 298.79% |
| Total Receivables | 42.21% | -24.16% | 61.45% | -27.94% | -1.74% |
| Inventory | 19.09% | -13.92% | 0.79% | -9.93% | 14.26% |
| Prepaid Expenses | -12.66% | 66.63% | 67.54% | -44.51% | 14.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.08% | -8.65% | -7.15% | -8.26% | 176.76% |
|
|
|||||
| Total Current Assets | 1.08% | -8.65% | -7.15% | -8.26% | 176.76% |
| Net Property, Plant & Equipment | -1.46% | -1.93% | -2.12% | -1.39% | -2.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -100.00% | -3.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.19% | -0.17% | -0.19% | -21.76% | -0.39% |
| Total Assets | 0.80% | -7.76% | -6.50% | -9.20% | 125.58% |
|
|
|||||
| Total Accounts Payable | 19.37% | 35.86% | 32.94% | -45.87% | 17.89% |
| Total Accrued Expenses | -43.23% | 19.28% | -11.44% | 22.36% | -28.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.78% | 5.72% | 5.85% | 9.61% | 6.07% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.10% | -16.86% | -0.49% |
| Total Other Current Liabilities | 0.00% | 0.00% | 0.10% | -16.86% | -0.49% |
| Total Current Liabilities | -3.01% | 24.51% | 9.05% | -23.05% | -1.37% |
|
|
|||||
| Total Current Liabilities | -3.01% | 24.51% | 9.05% | -23.05% | -1.37% |
| Long-Term Debt | 3.88% | 4.03% | 4.20% | 4.39% | 4.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.01% | -2.81% | -2.52% | -0.97% | -2.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00% | 1.33% | -0.08% | -8.60% | 0.92% |
| Total Liabilities | 0.98% | 3.99% | 1.50% | -7.68% | 1.17% |
|
|
|||||
| Common Stock & APIC | 7.31% | 0.77% | 0.52% | 1.21% | 39.05% |
| Retained Earnings | -6.31% | -4.93% | -3.44% | -0.83% | -4.02% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.29% | -32.44% | -28.02% | 2.26% | 65.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.29% | -32.44% | -28.02% | 2.26% | 65.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.29% | -32.44% | -28.02% | 2.26% | 65.91% |
|
|
|||||